With malaria being implicated in a number of these mechanisms [3,5,38] coupled with the possibility of multiple bouts of malaria in a lifetime, the seeming increased HOMA-B with increased galectin-3 observed in the non-diabetic respondents who had malaria in the current study connotes an increased diabetogenic risk. The gene discussed is LGALS3; the disease is malaria.